Cargando…

Inequality in the Survival of Patients With Head and Neck Cancer in Scotland

Background: Socioeconomic inequalities impact on the survival of head and neck cancer (HNC) patients, but there is limited understanding of the explanations of the inequality, particularly in long-term survival. Methods: Patients were recruited from the Scottish Audit of Head and Neck Cancer between...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingarfield, Kate, McMahon, Alex Douglas, Douglas, Catriona M., Savage, Shirley-Anne, MacKenzie, Kenneth, Conway, David I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349751/
https://www.ncbi.nlm.nih.gov/pubmed/30723696
http://dx.doi.org/10.3389/fonc.2018.00673
_version_ 1783390307770957824
author Ingarfield, Kate
McMahon, Alex Douglas
Douglas, Catriona M.
Savage, Shirley-Anne
MacKenzie, Kenneth
Conway, David I.
author_facet Ingarfield, Kate
McMahon, Alex Douglas
Douglas, Catriona M.
Savage, Shirley-Anne
MacKenzie, Kenneth
Conway, David I.
author_sort Ingarfield, Kate
collection PubMed
description Background: Socioeconomic inequalities impact on the survival of head and neck cancer (HNC) patients, but there is limited understanding of the explanations of the inequality, particularly in long-term survival. Methods: Patients were recruited from the Scottish Audit of Head and Neck Cancer between 1999 and 2001 and were linked to mortality data as at 30th September 2013. Socioeconomic status was determined using the area-based Carstairs 2001 index. Overall and disease-specific survival were calculated using the Kaplan-Meier method with 95% confidence intervals (CI's) at 1-, 5-, and 12-years. Net survival at 1-, 5-, and 12-years was also computed with 95% CIs. Cox proportional hazard models with 95% CIs were used to determine the explanations for the inequality in survival by all-cause mortality and disease-specific mortality with 95% CIs. Results: Most patients were from the most deprived group, and were more likely to smoke, drink, have cancer of a higher stage and have a lower WHO Performance Status. A clear gradient across Carstairs fifths for unadjusted overall and disease-specific survival was observed at 1-, 5-, and 12-years for patients with HNC. Following the adjustment for multiple patient, tumor and treatment factors, the inequality in survival for patients with HNC had attenuated and was no longer statistically significant at 1-, 5-, and 12-years. Conclusion: A clear gradient across Carstairs fifths for unadjusted overall, disease-specific and net survival was observed at 1-, 5-, and 12-years for HNC patients in Scotland from 1999 to 2001. This study concludes that explanations for the inequality in the survival of patients with HNC are not straightforward, and that many factors including various patient, tumor and treatment factors play a part in the inequality in the survival of patients with HNC.
format Online
Article
Text
id pubmed-6349751
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63497512019-02-05 Inequality in the Survival of Patients With Head and Neck Cancer in Scotland Ingarfield, Kate McMahon, Alex Douglas Douglas, Catriona M. Savage, Shirley-Anne MacKenzie, Kenneth Conway, David I. Front Oncol Oncology Background: Socioeconomic inequalities impact on the survival of head and neck cancer (HNC) patients, but there is limited understanding of the explanations of the inequality, particularly in long-term survival. Methods: Patients were recruited from the Scottish Audit of Head and Neck Cancer between 1999 and 2001 and were linked to mortality data as at 30th September 2013. Socioeconomic status was determined using the area-based Carstairs 2001 index. Overall and disease-specific survival were calculated using the Kaplan-Meier method with 95% confidence intervals (CI's) at 1-, 5-, and 12-years. Net survival at 1-, 5-, and 12-years was also computed with 95% CIs. Cox proportional hazard models with 95% CIs were used to determine the explanations for the inequality in survival by all-cause mortality and disease-specific mortality with 95% CIs. Results: Most patients were from the most deprived group, and were more likely to smoke, drink, have cancer of a higher stage and have a lower WHO Performance Status. A clear gradient across Carstairs fifths for unadjusted overall and disease-specific survival was observed at 1-, 5-, and 12-years for patients with HNC. Following the adjustment for multiple patient, tumor and treatment factors, the inequality in survival for patients with HNC had attenuated and was no longer statistically significant at 1-, 5-, and 12-years. Conclusion: A clear gradient across Carstairs fifths for unadjusted overall, disease-specific and net survival was observed at 1-, 5-, and 12-years for HNC patients in Scotland from 1999 to 2001. This study concludes that explanations for the inequality in the survival of patients with HNC are not straightforward, and that many factors including various patient, tumor and treatment factors play a part in the inequality in the survival of patients with HNC. Frontiers Media S.A. 2019-01-22 /pmc/articles/PMC6349751/ /pubmed/30723696 http://dx.doi.org/10.3389/fonc.2018.00673 Text en Copyright © 2019 Ingarfield, McMahon, Douglas, Savage, MacKenzie and Conway. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ingarfield, Kate
McMahon, Alex Douglas
Douglas, Catriona M.
Savage, Shirley-Anne
MacKenzie, Kenneth
Conway, David I.
Inequality in the Survival of Patients With Head and Neck Cancer in Scotland
title Inequality in the Survival of Patients With Head and Neck Cancer in Scotland
title_full Inequality in the Survival of Patients With Head and Neck Cancer in Scotland
title_fullStr Inequality in the Survival of Patients With Head and Neck Cancer in Scotland
title_full_unstemmed Inequality in the Survival of Patients With Head and Neck Cancer in Scotland
title_short Inequality in the Survival of Patients With Head and Neck Cancer in Scotland
title_sort inequality in the survival of patients with head and neck cancer in scotland
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349751/
https://www.ncbi.nlm.nih.gov/pubmed/30723696
http://dx.doi.org/10.3389/fonc.2018.00673
work_keys_str_mv AT ingarfieldkate inequalityinthesurvivalofpatientswithheadandneckcancerinscotland
AT mcmahonalexdouglas inequalityinthesurvivalofpatientswithheadandneckcancerinscotland
AT douglascatrionam inequalityinthesurvivalofpatientswithheadandneckcancerinscotland
AT savageshirleyanne inequalityinthesurvivalofpatientswithheadandneckcancerinscotland
AT mackenziekenneth inequalityinthesurvivalofpatientswithheadandneckcancerinscotland
AT conwaydavidi inequalityinthesurvivalofpatientswithheadandneckcancerinscotland